Perspectives from those who live it every day.
In this On Target podcast, Dr Akila Viswanathan talks with Dr Fred Bunz about cancer genetics and the cell mutations that lead to the growth… Read More »On Target with Dr Akila Viswanathan – Cancer Genetics
Last week's U.S. Supreme Court decision on Myriad's breast cancer gene patents sparked many comments from patients, the public and scientists. Here's what several Johns… Read More »Gene Patents Get Supreme Decision
***The following post was written by Dr. John Fetting at the Johns Hopkins Kimmel Cancer Center. After 30 years as a breast cancer medical oncologist,… Read More »Preventing the Return of Breast Cancer: Recipe for a New Era
The following blog post was submitted and written by representatives at the Lustgarten Foundation. Johns Hopkins and the Sanger Institute published two papers in the journal Nature describing how pancreatic cancer develops far more slowly than once thought. Major media outlets covering the news included The New York Times, Bloomberg News, Reuters, CBS News, Science News, WebMD and Health Day. Read the Johns Hopkins' news release for more information.
The Lustgarten Foundation, the nation’s largest private funder of pancreatic cancer research, applauds the work of cooperating investigators at the Johns Hopkins Medical Institutions and the Sanger Institute on their groundbreaking research in the area of pancreatic cancer. The studies, which were reported online Wednesday, October 27, in Nature, affirm early detection and screening as promising areas of investigation that hold significant potential for saving lives.